Zobrazeno 1 - 5
of 5
pro vyhledávání: '"José V. Madruga"'
Publikováno v:
Archivo Español de Arqueología, Vol 86, Pp 279-292 (2013)
Se describen cuatro altares inscritos recientemente descubiertos en La Vera, comarca cacereña situada en la orilla septentrional del río Tiétar. De las nuevas inscripciones, tres son altares dedicados a lo que se han llamado “dioses indígenas
Externí odkaz:
https://doaj.org/article/90148ac85340410990d7d88135247c65
Publikováno v:
Gerión, Vol 12 (1994)
Sin resumen
Externí odkaz:
https://doaj.org/article/7c7e8acdcb3548da9264a289c13e6122
Autor:
Judith A. Aberg, Bronagh Shepherd, Marcia Wang, Jose V. Madruga, Fernando Mendo Urbina, Christine Katlama, Shannon Schrader, Joseph J. Eron, Princy N. Kumar, Eduardo Sprinz, Margaret Gartland, Shiven Chabria, Andrew Clark, Amy Pierce, Max Lataillade, Allan R. Tenorio
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 9, Pp 2321-2335 (2023)
Abstract Introduction Efficacy and safety of the attachment inhibitor fostemsavir + optimized background therapy (OBT) were evaluated through 48 and 96 weeks in the phase 3 BRIGHTE trial in heavily treatment-experienced (HTE) adults failing their cur
Externí odkaz:
https://doaj.org/article/8218d8a5b6c34c1bb1da2843ae2d87e4
Autor:
Eduardo, Sprinz, Eduardo M, Netto, Maria, Patelli, J S, Lima, Maria Patelli J S, Lima, Juvênao J D, Furtado, Margareth, da Eira, Roberto, Zajdenverg, José V, Madruga, David S, Lewi, Alcyone A, Machado, Rogério J, Pedro, Marcelo A, Soares
Publikováno v:
AIDS research and human retroviruses. 25(9)
Infection with drug-resistant human immunodeficiency virus type 1 (HIV-1) has been documented in all countries that have surveyed for it and may result in an unfavorable response to therapy. The prevalence and characteristics of individuals with tran
Autor:
Christine, Katlama, Richard, Haubrich, Jacob, Lalezari, Adriano, Lazzarin, José V, Madruga, Jean-Michel, Molina, Mauro, Schechter, Monika, Peeters, Gaston, Picchio, Johan, Vingerhoets, Brian, Woodfall, Goedele, De Smedt, W, Towner
Publikováno v:
AIDS, 23(17), 2289-2300. Lippincott Williams & Wilkins
AIDS (London, England), 23(17), 2289-2300. Lippincott Williams and Wilkins
AIDS (London, England), 23(17), 2289-2300. Lippincott Williams and Wilkins
Objective: To evaluate the efficacy, safety and virologic resistance profile of etravirine (TMC125), a next-generation nonnucleoside reverse transcriptase inhibitor, over 48 weeks in treatment-experienced adults infected with HIV-1 strains resistant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f89989e7c39e9276635671dde1c4a2a
https://pure.eur.nl/en/publications/7ae303da-5a7d-4cbc-b033-2129a0526f99
https://pure.eur.nl/en/publications/7ae303da-5a7d-4cbc-b033-2129a0526f99